Real-Time Simulation of Ablation Physics
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
710
NCT04554277
Medico-economic Evaluation of Therapeutic Adaptation Guided by the Soluble Suppression of Tumorigenicity 2 (sST-2) Biomarker in the Management of Patients With Acute Heart Failure
Phase: N/A
Role: Collaborator
Start: Apr 27, 2021
Completion: Jan 31, 2027
Loading map...